DAMPs such as HMGB1 and serum amyloid A 1 protein, secreted by breast cancer cells and elevated in the plasma and tumor biopsies from patients with advanced triple-negative breast tumors, induce an immunosuppressive response in neutrophils via TLR2 [34,56]. This evidence concerns the gene TLR2 and breast carcinoma.